Last update 16 May 2024

Ifenprodil Tartrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ifenprodil, Ifenprodil tartrate (JP17)
+ [5]
Mechanism
NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (30 Mar 1982),
RegulationOrphan Drug (US)
Login to view First Approval Timeline

Structure

Molecular FormulaC46H60N2O10
InChIKeyDMPRDSPPYMZQBT-CEAXSRTFSA-N
CAS Registry23210-58-4
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Vertigo
JP
30 Mar 1982
Peripheral Vascular Diseases---
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CoughPhase 2
NZ
29 Jul 2020
CoughPhase 2
AU
29 Jul 2020
Idiopathic Pulmonary FibrosisPhase 2
NZ
29 Jul 2020
Idiopathic Pulmonary FibrosisPhase 2
AU
29 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
(gsqqzjjyeg) = llsgphzdsc xbsjjzonmg (czwrjqeqta )
Positive
22 Nov 2023
Phase 2
-
(wnrsejkuzy) = no worsening iwkkcptqng (qpattjgzyo )
Positive
01 Sep 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free